By the same token, findings in an animal model of polycystic ovary syndrome (PCOS) indicated that thylakoid-treated rats showed reduced weight, attenuated HOMA-IR and insulin levels, and improved serum concentrations of lipids (58). The gene discussed is INS; the disease is polycystic ovary syndrome.